In:
Journal of Gastroenterology and Hepatology, Wiley, Vol. 21, No. 8 ( 2006-08), p. 1269-1275
Abstract:
Background: Oxidative damage of the erythrocyte membrane plays an important role in ribavirin‐induced anemia. The purpose of the present paper was to assess whether supplementation of α‐tocopherol and ascorbic acid (vitamins) causes changes in the erythrocyte membrane fatty acid composition during interferon and ribavirin combination therapy for chronic hepatitis C patients. Methods: Fatty acid compositions in erythrocyte membrane phospholipids were determined by gas chromatography at 0, 2, 4, 8 weeks, and at the end of combination therapy (26 weeks) for interferon with ribavirin in 32 patients with chronic hepatitis C who were randomized to receive vitamins or not (controls). Results: Good compliance with orally administered vitamins and ribavirin were confirmed by their concentrations in erythrocytes or plasma. The hemoglobin level was negatively correlated with the ribavirin concentration at 8 weeks ( r = 0.59, P = 0.01) after initiation of therapy in controls, but not in the vitamin group. Among the 26 kinds of fatty acids analyzed, only eicosapentaenoic acid (EPA) significantly decreased at 8 weeks after initiation of therapy ( P = 0.03) and at the end of therapy ( P = 0.004) in controls. Vitamins did not inhibit ribavirin‐induced anemia, but attenuated the decrease of EPA in erythrocytes. The EPA level was negatively correlated with the drop in hemoglobin levels at 8 weeks after initiation of therapy in controls ( r = 0.58, P = 0.015), but not in the vitamin group. Conclusions: Supplementation of α‐tocopherol and ascorbic acid attenuates the ribavirin‐induced decrease of EPA in erythrocyte membrane phospholipids in chronic hepatitis C patients.
Type of Medium:
Online Resource
ISSN:
0815-9319
,
1440-1746
DOI:
10.1111/jgh.2006.21.issue-8
DOI:
10.1111/j.1440-1746.2006.04378.x
Language:
English
Publisher:
Wiley
Publication Date:
2006
detail.hit.zdb_id:
2006782-3
Permalink